National Consumer Surveys on Understanding the Risks and Benefits of FDA-Regulated Medical Products
New collection (Request for a new OMB Control Number)
No
Regular
Approved with change
12/20/2011
07/05/2011
This collection is approved under the understanding that FDAÂs presentation of results will describe the data as exploratory and descriptive. Due to the purposeful nature of the statistical sample, the results cannot be generalized to the U.S. population.
table that charts list comparision
Inventory as of this Action
Requested
Previously Approved
12/31/2014
36 Months From Approved
9,730
0
0
1,428
0
0
0
0
0
The information collected will be used by FDA in the development of more effective risk communication strategies and messages. FDA recognizes that these surveys should only be used for internal purposes (e.g., to better understand consumer perceptions). The data will not be used for the purposes of making policy or regulatory decisions.
The surveys will provide FDA insight as to how well the public understands and incorporates risk/benefit information into their belief structures, and how well the public understands the context within which FDA makes decisions on medical product recalls and warnings.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.